Together, these observations make it highly likely that it was inhibition of TNFR1 signaling and subsequent enhancement of adaptive immunity, not antibody-dependent innate responses, that accounted for inhibition of tumor growth. The gene discussed is TNFRSF1A; the disease is neoplasm.